CLINICAL_TRIALS
trial_result
· 2024-12-10
Clinical Trial Update: Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma [Phase 2, Phase 3]
Summary
This document reports the completion and posted results from a Phase 2/3 clinical trial evaluating pembrolizumab in patients with advanced malignant pleural mes…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Canadian Cancer Trials Group | Conditions: Mesothelioma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-12-10